Consent Vault, Inc receives issuance of a patient for a groundbreaking AI- and machine learning–enabled consent management system designed to accelerate data-driven insights, data enablement and governance.
The current application of this patented technology empowers patients to define how their clinical, genomic, and real-world data may be used—specifying access by data type, purpose, authorized parties, and conditions such as compensation or time limits. AI agents evaluate third-party data requests in real time against these personalized permissions, enabling secure, compliant data sharing without exposing or storing sensitive data locally.
Purpose-built for the demands of precision medicine, the system supports dynamic consent updates, cohort-based queries (e.g., by tumor type, biomarker, or treatment history), and monetization pathways that benefit patients and data contributors alike. This innovation lays the foundation for scalable, ethical data exchange across community oncology networks, clinical research, and life sciences partnerships.
